REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Gulf Pharmaceutical Industries Psc (United Arab Emirates)

Main Activities: Medicinal and Botanical Manufacturing | Pharmaceutical Preparation Manufacturing
Full name: Gulf Pharmaceutical Industries Psc Profile Updated: October 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Julphar Gulf Pharmaceuticals Industries is a pharmaceutical company specializing in Julphar Diabetes Solutions, General Medicines, and a consumer division. The company produces a variety of medicines, injections, and consumer healthcare products targeting major therapeutic segments. Julphar is known for its production of insulin and claims to be one of the largest pharmaceutical companies in the Middle East and Africa, with state-of-the-art manufacturing facilities.

Headquarters
Airport Road - Al Deqdaqa, P.O Box 997
Ras Al Khaimah; Northern Emirates;

Contact Details: Purchase the Gulf Pharmaceutical Industries Psc report to view the information.

Website: http://www.julphar.net

Basic Information
Total Employees:
Purchase the Gulf Pharmaceutical Industries Psc report to view the information.
Outstanding Shares:
Purchase the Gulf Pharmaceutical Industries Psc report to view the information.
Financial Auditors:
Purchase the Gulf Pharmaceutical Industries Psc report to view the information.
Incorporation Date:
1980
Key Executives
Purchase this report to view the information.
Chairperson
Purchase this report to view the information.
Vice Chairperson
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Purchase this report to view the information.
Director / Member of the Management Board
Ownership Details
Purchase this report to view the information.
24.094%
Purchase this report to view the information.
12.24%
Purchase this report to view the information.
9.131%
Purchase this report to view the information.
9%
Purchase this report to view the information.
7.579%
Subsidiaries
Diabtec L.L.C.
100%
Julphar Gulf Pharmaceuticals Kenya Limited (Kenya)
100%
Julphar Life L.L.C
100%
Company Performance
Financial values in the chart are available after Gulf Pharmaceutical Industries Psc report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency AED. Absolute financial data is included in the purchased report.
Net sales revenue
2.1%▲
Total operating revenue
-1.81%▼
Operating profit (EBIT)
N/A
EBITDA
86.52%▲
Net Profit (Loss) for the Period
94.75%▲
Total assets
-1.2%▼
Total equity
-9.73%▼
Operating Profit Margin (ROS)
N/A
Net Profit Margin
5.01%▲
Return on Equity (ROE)
4.93%▲
Debt to Equity Ratio
11.72%▲
Quick Ratio
0.01%▲
Cash Ratio
0.02%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo